A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: r. peter Dale who wrote ()	8/24/1997 8:03:00 AM
From: r. peter Dale	of 171

Self serving post #1: (why else would I start a thread if not to advertise my own picks?) 1. Ariad Pharmaceuticals (ARIA): Boston area company with top flight personal and a unique focus (drugs to block highly specific intercellular signaling systems). Currently given a perfect '1.0' rating by the four analysts who cover ARIA and, as of yesterday, rated #1 out of 129 companies in its sector by Zachs. 2. Univec (UNVC): Fairly recent IPO with locking syringe device(s) which effectively blocks disease transmission by reuse of contaminated needles, etc. Has solid partnership with the WHO to address the spread of meningitis. Chart looks like Titanic. Appears to have good product, increasing demand, and lucrative niche. 3. Fountain Pharmaceuticals (FPHI): Develops microencapsulation drug delivery systems (at least in theory). Until recently, dead-in-the-water penny stock with not much of any noteworthy product. June, 1997, received significant financing from investor group, rearranged its board, and stock has quadrupled (to $0.24...). You may want to avoid placing your children's college funds in this one. Best wishes, Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext